Alfuzosin and tamsulosin appear to provide higher rates of successful trial without catheter. Most nonpharmacological treatment options have not been evaluated in patients with urinary retention secondary to benign prostatic obstruction. Consequently, the evidence is inconclusive regarding the efficacy of nonpharmacological interventions for the management of urinary retention secondary to benign prostatic obstruction.